AbbVie Inc annual earnings per share (EPS) for fiscal 2025 was $10.00, a decrease of 1.2% from $10.12 in fiscal 2024. Trailing-twelve-month earnings per share (EPS) is $10.19. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $10.19 | $10.00 | $10.12 | $11.11 | $13.79 | $12.70 | $10.51 | $8.94 | $7.91 | $5.59 | $4.82 | $4.28 | $3.31 | $3.14 | $0.98 | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $2.65 | $2.71 | $1.86 | $2.97 | $2.46 | $2.16 | $3.00 | $2.65 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ABBV metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All ABBV financial statements → Interactive ABBV charts →
About TickerBase · Data methodology & sources